MARRONE BIO INNOVATIONS INC's ticker is MBII and the CUSIP is 57165B106. A total of 56 filers reported holding MARRONE BIO INNOVATIONS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -66.7% | 2,000 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | -25.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | +100.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 2,000 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | -25.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2018 | $4,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 10,323,247 | $16,425,000 | 2.21% |
| ICM ASSET MANAGEMENT INC/WA | 262,900 | $481,000 | 0.34% |
| WADDELL & REED FINANCIAL INC | 24,714,892 | $45,228,000 | 0.10% |
| THOMPSON DAVIS & CO., INC. | 10,000 | $18,000 | 0.04% |
| Whitegate Investment Counselors, Inc. | 15,000 | $27,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 22,728 | $42,000 | 0.00% |
| PRIMECAP MANAGEMENT CO/CA/ | 2,625,600 | $4,805,000 | 0.00% |
| Allworth Financial LP | 10,766 | $20,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 78,906 | $144,000 | 0.00% |
| NORTHERN TRUST CORP | 524,475 | $959,000 | 0.00% |